we care about the cure of cancer

we implement interventional guidance through imaging

we define new standards in tumor treatments

Previous

Next

SurgicEye® at a glance

Products

News

  • News
    News

    SurgicEye takes part in EANM 2019 in Barcelona

    SurgicEye and Crystal Photonics show their solutions for radio guided surgery at EANM (joint booth number 001). The offered products go from gamma probes providing acoustic feedback to 3D imaging and navigation as provided by the declipse®SPECT device. All devices will be on the booth and you could get hands-on sessions with the team from both companies.   We are looking forward seeing you soon.

  • News
    News

    Meet SurgicEye at ESSO 2019 together with experts for radioguided surgery

    About SurgicEye® GmbH: SurgicEye® GmbH is a pioneer in intra-operative 3-D imaging for surgical navigation. The company develops breakthrough tools in the fight against cancer. The declipse®SPECT from SurgicEye® is the world’s first FDA and CE certified product for intra-operative three dimensional visualization of radio labeled tissues and allows the detection, localization and guided biopsy of sentinel lymph…

What clinicians say

  • Prof. Dr. René Hornung
    Prof. Dr. René HornungHead of Department of Gynecology Kantonsspital St. Gallen, Switzerland
    The 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive surgery in gynecologic oncology. Sentinel lymph node biopsy during laparoscopic procedures seems to be easily feasible and may in the near future become standard of care for cervical and endometrial cancers.
  • Dr. Sergi Vidal Sicart
    Dr. Sergi Vidal SicartNuclear Medicine Specialist, Hospital Clínic Barcelona, Spain
    The 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers a realistic view of the surgical procedure suited for the operating room.
  • Dr. Omgo E. Nieweg
    Dr. Omgo E. NiewegSurgeon, The Netherlands Cancer Institute Amsterdam, the Netherlands
    The innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional cancer types in locations with a more intricate anatomy and cancer types with more complex lymph drainage.
  • Prof. Dr. Marion Kiechle
    Prof. Dr. Marion KiechleDirector of the Women’s Hospital Klinikum rechts der Isar Munich, Germany
    The declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for every individual patient.

Partners

Do you want to know more?

Contact us